This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Santoro A . Advanced soft tissue sarcoma: how many more trials with anthracyclines and ifosfamide. Ann Oncol 1999; 10: 151–154.
Van Glabekke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens – a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150–157.
Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750–758.
Worley BS, van den Broeke LT, Goletz TJ et al. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res 2001; 61: 6868–6875.
Pedrazzoli P, Da Prada GA, Giorgiani G et al. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Cancer 2002; 94: 2409–2415.
Makimoto A, Kami M, Mineishi R . Reduced-intensity allogeneic stem-cell transplantation (RIST) for patients including children with refractory sarcomas. Proc ASCO 2003; 22: 3355.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Castagna, L., Sarina, B., Todisco, E. et al. Lack of activity of allogeneic stem cell transplantation with reduced-intensity conditioning regimens in advanced sarcomas. Bone Marrow Transplant 35, 421–422 (2005). https://doi.org/10.1038/sj.bmt.1704774
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704774
This article is cited by
-
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
Nature Clinical Practice Oncology (2008)